Patent ID: 11883374
Assignee: SHANGHAI AUCTA PHARMACEUTICALS CO., LTD.
Field: Pharmaceuticals (Chemistry)
Classification: CPC A | IPC A

Claim 14:
15. A method of providing an extended release of lacosamide in a subject, comprising administering to the subject a dosage form of claim 1, wherein the amount of the lacosamide or the pharmaceutically acceptable salt thereof and the amount of the pH independent extended release agent are selected so that the dosage form provides an in-vitro dissolution according the following:
(a) from about 11% to about 18% in 1 hour,
(b) from about 20% to about 35% in 2 hours,
(c) from about 40% to about 70% in 4 hours,
(d) from about 65% to about 95% in 6 hours, and
(e) more than about 90% in 12 hours,
wherein the in-vitro dissolution is determined using a USP type 1 dissolution system (Basket Apparatus) at 100 rpm and a temperature of 37±0.5° C. in 900 ml of pH 6.8 phosphate buffer for 12 hours.